PLP1 Gene SPG2 Genetic Test sale cost 4400 AED
KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test sale cost 4400 AED KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
VPS37A Gene SPG53 Genetic Test sale cost 4400 AED VPS37A Gene SPG53 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

PLP1 Gene SPG2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PLP1 gene SPG2 genetic test is a specialized diagnostic procedure aimed at detecting mutations in the PLP1 gene, which are associated with Pelizaeus-Merzbacher Disease (PMD) and Spastic Paraplegia Type 2 (SPG2). These conditions are part of a group of genetic disorders known as leukodystrophies, which affect the brain and spinal cord, particularly impacting the myelin sheath that insulates nerve fibers. PMD and SPG2 are characterized by a range of symptoms including motor and cognitive developmental delays, muscle stiffness (spasticity), and involuntary eye movements.

Conducted at DNA Labs UAE, a leading facility in genetic testing, the PLP1 gene SPG2 genetic test provides critical insights for families and healthcare providers. By analyzing an individual’s DNA, the test can confirm a diagnosis, guide treatment options, and offer information on the risk of passing the condition to future generations. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expert analysis involved in identifying the specific genetic mutations out of the vast complexity of the human genome.

This genetic test represents a crucial step for affected families in understanding their condition, enabling informed decisions regarding care and management. It is recommended for individuals showing symptoms of PMD or SPG2, or for those with a family history of these disorders, as early diagnosis can significantly influence the approach to treatment and support.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PLP1 Gene SPG2 Genetic Test

At DNA Labs UAE, we offer the PLP1 Gene SPG2 Genetic Test at a cost of 4400.0 AED. This test is used to diagnose spastic paraplegia type 2 (SPG2), a genetic disorder characterized by progressive weakness and stiffness in the legs.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the PLP1 Gene SPG2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. A genetic counseling session will also be conducted to draw a pedigree chart of family members affected with PLP1 Gene SPG2.

Test Details

The PLP1 gene, also known as the proteolipid protein 1 gene, is associated with spastic paraplegia type 2 (SPG2). NGS, or next-generation sequencing, is a genetic testing method that allows for the simultaneous analysis of multiple genes. The PLP1 gene will be sequenced to identify any mutations or variants that may be causing the disorder.

To perform the test, a blood or saliva sample will be collected from the individual. The DNA will then be extracted and analyzed using NGS technology. The results will be interpreted by a geneticist or genetic counselor to determine if any disease-causing mutations are present.

It is important to note that this genetic test for SPG2 using NGS should be ordered by a healthcare professional specializing in genetics. They will consider the individual’s symptoms, medical history, and family history before recommending the test. Genetic counseling is also recommended before and after the test to discuss the implications of the results and provide support.

Test Name PLP1 Gene SPG2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PLP1 Gene SPG2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PLP1 Gene SPG2
Test Details

The PLP1 gene, also known as the proteolipid protein 1 gene, is associated with a genetic disorder called spastic paraplegia type 2 (SPG2). This disorder is characterized by progressive weakness and stiffness in the legs, leading to difficulty walking.

NGS, or next-generation sequencing, is a genetic testing method that allows for the simultaneous analysis of multiple genes. It involves sequencing the DNA or RNA of an individual to identify any genetic variants or mutations that may be present.

A genetic test for SPG2 using NGS would involve sequencing the PLP1 gene to identify any mutations or variants that may be causing the disorder. This can help in confirming a diagnosis, providing information about disease progression, and informing treatment options.

The test may involve collecting a blood or saliva sample from the individual, extracting the DNA, and then performing the NGS analysis on the PLP1 gene. The results would then be analyzed and interpreted by a geneticist or genetic counselor to determine if any disease-causing mutations are present.

It’s important to note that genetic testing for SPG2 using NGS is typically ordered by a healthcare professional who specializes in genetics. They will consider the individual’s symptoms, medical history, and family history before recommending the test. Genetic counseling is also usually recommended before and after the test to discuss the implications of the results and provide support.

SKU: TEST-1995 Category:

Related products